Cost-utility analysis of biologic disease-modifying antirheumatic drugs (bDMARDs), targeted synthetic DMARDs (tsDMARDs) and biosimilar DMARDs (bsDMARDs) combined with methotrexate... by Juthamas Prawjaeng, Pattara Leelahavarong, Nuttakarn Budtarad, Songyot Pilasant, Chonticha Chanjam, Wanruchada Katchamart, Pongthorn Narongroeknawin, Tasanee Kitumnuaypong

Get full text

Thai Osteoporosis Foundation (TOPF) position statements on management of osteoporosis by T. Songpatanasilp, C. Sritara, W. Kittisomprayoonkul, S. Chaiumnuay, H. Nimitphong, N. Charatcharoenwitthaya, C. Pongchaiyakul, S. Namwongphrom, T. Kitumnuaypong, W. Srikam, P. Dajpratham, V. Kuptniratsaikul, U. Jaisamrarn, K. Tachatraisak, S. Rojanasthien, P. Damrongwanich, W. Wajanavisit, S. Pongprapai, B. Ongphiphadhanakul, N. Taechakraichana

Get full text